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Yates DT, Cadaret CN, Beede KA, Riley HE, Macko AR,
Anderson MJ, Camacho LE, Limesand SW. Intrauterine growth-
restricted sheep fetuses exhibit smaller hindlimb muscle fibers and
lower proportions of insulin-sensitive Type I fibers near term. Am J
Physiol Regul Integr Comp Physiol 310: R1020–R1029, 2016. First
published April 6, 2016; doi:10.1152/ajpregu.00528.2015.—Intra-
uterine growth restriction (IUGR) reduces muscle mass and insulin
sensitivity in offspring. Insulin sensitivity varies among muscle fiber
types, with Type I fibers being most sensitive. Differences in fiber-
type ratios are associated with insulin resistance in adults, and thus we
hypothesized that near-term IUGR sheep fetuses exhibit reduced size
and proportions of Type I fibers. Placental insufficiency-induced
IUGR fetuses were 54% smaller (P  0.05) than controls and
exhibited hypoxemia and hypoglycemia, which contributed to 6.9-
fold greater (P 0.05) plasma norepinephrine and53% lower (P
0.05) plasma insulin concentrations. IUGR semitendinosus muscles
contained less (P 0.05) myosin heavy chain-I protein (MyHC-I) and
proportionally fewer (P  0.05) Type I and Type I/IIa fibers than
controls, but MyHC-II protein concentrations, Type II fibers, and
Type IIx fibers were not different. IUGR biceps femoris muscles
exhibited similar albeit less dramatic differences in fiber type propor-
tions. Type I and IIa fibers are more responsive to adrenergic and
insulin regulation than Type IIx and may be more profoundly im-
paired by the high catecholamines and low insulin in our IUGR
fetuses, leading to their proportional reduction. In both muscles, fibers
of each type were uniformly smaller (P  0.05) in IUGR fetuses than
controls, which indicates that fiber hypertrophy is not dependent on
type but rather on other factors such as myoblast differentiation or
protein synthesis. Together, our findings show that IUGR fetal mus-
cles develop smaller fibers and have proportionally fewer Type I
fibers, which is indicative of developmental adaptations that may help
explain the link between IUGR and adulthood insulin resistance.
fetal growth restriction; fetal programming; myocyte
A GROWING NUMBER OF STUDIES have linked intrauterine growth
restriction (IUGR) to insulin resistance, obesity, and metabolic
syndrome later in life (5, 31, 59, 61, 62, 68, 81). The fetal
adaptations underlying these complications have not been
fully characterized but likely include structural and func-
tional changes in skeletal muscle development, since muscle
is the primary site for insulin-stimulated glucose disposal
(27). Throughout life, IUGR-born individuals generally ex-
hibit less muscle mass and greater central fat deposition (3,
33, 43, 90), and we recently showed that semitendinosus
muscle fibers in IUGR fetal sheep are smaller near term due
in part to impaired myoblast proliferative capacity (86).
Moreover, protein analysis of muscle samples in other
studies have shown evidence of impaired insulin signaling
(39, 40, 63, 64). Reduced muscle growth and insulin-
stimulated glucose consumption may represent essential
nutrient-sparing adaptations in IUGR fetuses but also likely
contribute to insulin resistance and metabolic dysfunction in
adulthood (87, 89).
Skeletal muscle is composed of heterogeneous populations
of muscle fibers that can be classified by expression of different
myosin heavy chain (MyHC) isoforms, and rat studies have
shown that responsiveness to insulin differs among fiber types
(34, 38, 55). Insulin-stimulated glucose uptake rates are great-
est in Type I fibers (slow oxidative; MyHC-I) and lowest in
Type IIx fibers (fast glycolytic; MyHC-IIx). The response of
Type IIa fibers (fast oxidative/glycolytic; MyHC-IIa) to insulin
is intermediate between Type I and Type IIx myofibers. Each
skeletal muscle is composed of specific fiber-type ratios, and
composition differences in thigh muscles have been associ-
ated with insulin resistance in adult men (40, 49). We
postulate that IUGR conditions alter fetal fiber-type ratios in
a way that promotes development of insulin resistance in
IUGR skeletal muscle. Specifically, we would expect re-
duced proportions of the most insulin-sensitive fiber type:
Type I fibers. Furthermore, reductions in size may occur
disproportionately in Type I fibers and result in further
decreases in insulin sensitivity.
The objective of this study was to determine whether fiber
type-specific differences in size and ratios occur in IUGR fetal
skeletal muscles near the end of gestation. The study was
performed using a well-characterized IUGR model (26, 54, 71,
72) in which pregnant ewes are exposed to high ambient
temperatures for an extended period during midgestation to
generate natural placental insufficiency (11, 14, 32, 71). In
these animals, the reduced size and transport capacity (11, 69,
70, 80) of the placenta prevent it from meeting the nutrient
requirements for rapid fetal growth that occurs late in gesta-
tion, after animals are returned to thermoneutral conditions.
Hyperthermia-induced placental insufficiency results in pat-
terns of progressively worsening hypoxemia, hypoglycemia,
and asymmetrical fetal growth restriction (22, 48, 51, 53)
congruent to other models of placental insufficiency (21, 23–
25, 46, 60, 84) as well as humans (30, 36, 76). We evaluated
two commonly studied mixed-fiber type hindlimb muscles, the
semitendinosus and biceps femoris, that are similar-sized and
adjacently located. Under normal circumstances these muscles
express comparable fiber sizes, fiber-type ratios, and metabolic
enzyme profiles (35, 42, 44) but differences in vascularity and
innervation (67, 85), as well as temporal aspects of develop-
ment (29).
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MATERIALS AND METHODS
Animals and experimental treatments. Animal care and use was
approved by the Institutional Animal Care and Use Committee at The
University of Arizona, Tucson, AZ, which is accredited by the
American Association for Accreditation of Laboratory Animal Care.
Animal studies were performed at the University of Arizona Agricul-
tural Research Complex.
Columbia-Rambouillet crossbred ewes with singleton pregnancies
confirmed by ultrasound were obtained from Nebeker Ranch (Lan-
caster, CA). IUGR fetuses (n  7; 4 male, 3 female) were generated
by inducing placental insufficiency as previously described (48, 53).
Briefly, pregnant ewes were exposed to elevated ambient temperatures
(40°C for 12 h/day, 35°C for 12 h/day; dew point 22°C) from the 40th
to the 95th day of gestational age (dGA). Age-matched control fetuses
(n  6; 3 male, 3 female) were generated from ewes housed at 25°C
and pair-fed to the average daily intake of the IUGR group. At 120 
1 dGA, indwelling polyvinyl catheters were surgically placed in the
fetal abdominal aorta via the hindlimb pedal artery as previously
described (50, 52). Catheters were tunneled subcutaneously to the
flank of the ewe and exteriorized. At 132  1 dGA, a series of three
fetal blood samples were collected from each animal in 5-min inter-
vals as previously described (48, 88). Ewes and fetuses were eutha-
nized at 134  1 dGA with Euthansol (Merck Animal Health). Fetal,
placental, and organ weights were measured postmortem. Fetal sem-
itendinosus and biceps femoris muscles were collected for immuno-
histochemistry and gene expression analysis.
Blood sample analysis. Fetal blood samples were analyzed as
previously described (48, 88). Whole blood oxygen, carbon dioxide,
and pH levels were determined with an ABL 720 blood gas analyzer
(Radiometer, Copenhagen, Denmark). Plasma glucose and lactate
concentrations were determined with an YSI 2700 SELECT biochem-
istry analyzer (Yellow Springs Instruments, Yellow Springs, OH).
Plasma insulin and norepinephrine concentrations were determined by
commercial ELISA kits (Ovine Insulin, ALPCO Diagnostics, Wind-
ham, NH; 2-CAT, Rocky Mountain Diagnostics, Colorado Springs,
CO) as previously described (88), with intra-assay and inter-assay
coefficients of variance of less than 15% for each.
Immunohistochemistry. Central, cross-sectional biopsies of the
semitendinosus and biceps femoris muscles were fixed in 4% para-
formaldehyde and phosphate-buffered saline (PBS; pH 7.3), embed-
ded in OTC Compound, and frozen as previously described (18, 86).
Eight-micrometer sections were mounted on Fisherbrand Superfrost
Plus microscope slides (Thermo Fisher Scientific, Waltham, MA) and
immunostained. Briefly, tissues were washed in PBS with 0.1%
Triton-X-100 (Sigma-Aldrich) and then steamed with 10 mM citric
acid buffer (pH 6; Sigma-Aldrich) for antigen retrieval. Nonspecific
binding was blocked with 0.5% NEN blocking buffer (Perkin-Elmer,
Waltham, MA). Primary antiserum diluted in PBS  1% bovine
serum albumin was applied overnight at 4°C (primary antiserum was
excluded in negative controls). Fiber types were determined with
antibodies raised in the mouse against MyHC-I (BA-D5, 1:20; DSHB,
University of Iowa, Iowa City, IA), MyHC-II (F18, 1:20; DSHB),
MyHC-I/MyHC-IIa (BF-32, 1:20; DSHB), and MyHC-IIx (6H1,
1:150; DSHB) (13). Fibers were counterstained with rabbit antidesmin
(1:200; Sigma-Aldrich). Immunocomplexes were detected with affin-
ity-purified immunoglobulin antiserum conjugated to Alexa Fluor 594
(1:3,000; Invitrogen Life Technologies, Carlsbad, CA) or Alexa Fluor
488 (1:2,500; Jackson ImmunoResearch Laboratories, West Grove,
PA). Fluorescent images were visualized on a Leica DM5500 micro-
scope system and digitally captured with a Spot Pursuit 4 Megapixel
CCD camera (Diagnostic Instruments, Sterling Heights, MI). Images
were analyzed with Image Pro Plus 6.3 software (Media Cybernetics,
Silver Spring, MD) and ImageJ (National Institutes of Health,
Bethesda, MD) to determine fiber-type proportions and mean cross-
sectional areas. To prevent evaluator bias during morphometric as-
sessment, histological images were encoded to conceal animal and
treatment designations.
Myosin heavy chain electrophoresis. Snap-frozen muscle samples
(50 mg) were homogenized in 200 l of RIPA buffer containing
manufacturer recommended concentrations of Halt Protease and Halt
Phosphatase Inhibitor Cocktails (Thermo Fisher). Homogenates were
then sonicated and centrifuged (2500 g; 10 min), and supernatant was
collected. Total protein concentrations were determined by Pierce
BCA Assay (Thermo Fisher). Samples were incubated at room tem-
perature for 10 min, heated at 70°C for 10 min, combined with
Bio-Rad 4 Laemmli Sample Buffer (Bio-Rad, Hercules, CA) to a
1 concentration, and loaded at 10 g/well. MyHC isoforms were
separated by SDS-PAGE (66, 78). Stacking gels consisted of 47%
vol/vol glycerol (100%), 6% vol/vol acrylamide-bisacrylamide (50:1),
110 mM Tris (pH 6.7), 6 mM EDTA, 0.4% vol/vol SDS (10%), 0.1%
vol/vol ammonium persulfate (10%), and 0.05% vol/vol tetramethyl-
Table 1. Primers for qPCR
Gene Protein Primer Sequence Product Size Accession Number
MYH7 MyHC-I GAG ATG GCC GCG TTT GGG GAG 283 AB058898.1
GGC TCG TGC AGG AAG GTC AGC
MYH2 MyHC-IIa ACC GAA GGA GGG GCG ACT CTG 109 AB058896.1
GGC TCG TGC AGG TGG GTC ATC
MYH1 MyHC-IIx AAA GCG ACC GTG CAG AGC AGG 154 AB058897.1
GGC TCG TGC AGG TGG GTC ATC
RPS15 s15 ATC ATT CTG CCC GAG ATG GTG 134 AY949774.1
TGC TTT ACG GGC TTG TAG GTG
MYH, myosin heavy chain.
Table 2. Morphometric data
Variable Control (n  6) IUGR (n  7) P Value
dGA 135  0.5 134  0.5 NS
Uteroplacental mass, g
Uterus 491  48 398  48 NS
Placenta 297  31 131  29 0.01
Number of placentomes 89.3 6.6 74.2  6.2 NS
Average placentome
mass, g 3.34 0.33 2.01  0.31 0.01
Fetal mass, g
Fetus 3,279  199 1,491  184 0.01
Carcass 2,531  152 1,098  141 0.01
Carcass/fetus, % 77.2 0.6 73.5  0.6 0.01
Relative organ mass,
g/fetal kg
Brain 16.2  2.6 29.9  2.4 0.01
Heart 6.9  0.3 8.5  0.2 0.01
Liver 26.5  2.3 30.1  2.2 NS
Lungs 28.3  1.5 32.0  1.4 NS
Kidneys 6.5  0.9 8.3  0.9 NS
Spleen 2.9  0.3 2.0  0.3 NS
Values are means  SE; n, number of animals. NS, not significant.
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ethylenediamine (TEMED, 100%). Resolving gels were composed of
35% vol/vol glycerol (100%), 9% vol/vol acrylamide-bisacrylamide
(50:1), 230 mM Tris (pH 8.8), 115 mM glycine, 0.4% vol/vol SDS
(10%), 0.1% vol/vol ammonium per sulfate (10%), and 0.05% vol/vol
TEMED (100%). The upper running buffer consisted of 100 mM Tris,
150 mM glycine, 0.1% SDS, and 0.07% 2	-mercaptoethanol in
distilled water, and the lower running buffer consisted of 50 mM Tris,
75 mM glycine, and 0.05% SDS in distilled water. Electrophoresis
was performed on a Mini-PROTEAN Tetra Cell (Bio-Rad) at 4°C for
24 h at a constant 150 V. After electrophoresis, gels were stained
overnight with Gel-Code Blue (Thermo Fisher), destained in distilled
water, and imaged on an Odyssey infrared imaging system (LI-COR
Biosciences, Lincoln, NE). MyHC-I and collective MyHC-II bands
were measured by densitometry (Image Studio Lite Ver 5.0; LI-COR).
Myosin heavy chain Western immunoblot. Skeletal muscle proteins
were separated by SDS-PAGE and transferred to polyvinylidene
fluoride membranes as previously described (17, 52). Membranes
were incubated in Tris-buffered saline  0.1% Tween-20  5%
nonfat dry milk for 1 h to block nonspecific binding and then
incubated overnight at 4°C with mouse anti-MyHC-I or MyHC-II
primary antibodies diluted in Tris-buffered saline  0.1% Tween-20
 5% nonfat dry milk. MyHC immunoblots were normalized to
	-tubulin (1:3,000; RB-9249, Thermo Fisher). Immunocomplexes
were detected with goat antimouse IgM horseradish peroxidase-
conjugated secondary antibody (1:5,000; Santa Cruz Biotechnology,
Santa Cruz, CA) or with goat antimouse IgG horseradish peroxidase-
conjugated secondary antibody (1:20,000; Bio-Rad) using West Pico
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL) and
exposed to X-ray film. Densitometry values were determined with
ImageJ software.
Quantitative PCR. RNA was extracted from ground muscle (200
mg) using the QIAprep Spin MiniPrep kit (Qiagen, Valencia, CA) and
was reverse transcribed in triplicate (16). Oligonucleotide primers
(Table 1) were synthesized as previously described (17) and PCR
products were cloned into pCR II (Invitrogen) and confirmed with
nucleotide sequencing (University of AZ Genetics Core, Tucson, AZ)
(16). Primer efficiencies and standard curves were determined from
plasmid DNA, which were linear over six orders of magnitude.
Concentrations of mRNA for each gene were determined by qPCR
using SYBR Green (Qiagen) in an iQ5 Real-Time PCR Detection
System (Bio-Rad Laboratories). Samples were initially denatured
(95°C for 15 min) and then amplified with 45 cycles of denaturing
(96°C for 30 s), annealing (60–62°C for 30 s), and fluorescence
measurement during extension (72°C for 10 s). Melt curves were
performed after amplification to confirm product homogeneity.
mRNA concentrations for each gene of interest were determined from
triplicate cDNA and normalized to mRNA concentrations of ribo-
somal protein s15.
Statistical analysis. All data were analyzed by ANOVA using the
GLM procedure of SAS (SAS Institute, Cary NC) to determine
treatment effects. Fetal sex was initially included as a covariate in all
analysis but was only significant for liver weight and was removed
from the model for all other parameters. For each fetus, values for
whole blood and plasma parameters represent the average of the three
blood samples. Mean semitendinosus and biceps femoris muscle fiber
cross-sectional areas were determined from a minimum of 300 fibers
across 10 nonoverlapping fields of view. The percentages of fibers
staining positive for each MyHC were determined from a minimum of
1,500 fibers per muscle. MyHC mRNA concentrations normalized to
the s15 housekeeping gene are expressed as the amount relative to
controls. Individual MyHC protein concentrations analyzed by elec-
trophoresis are expressed as the percentage of total MyHC protein.
Individual MyHC protein concentrations analyzed by Western immu-
noblot were normalized to 	-tubulin protein content and are expressed
as the relative density compared with controls. Pearson correlation
analyses were performed using the CORR procedure of SAS. All data
are expressed as means  SE.
Table 3. Fetal blood and plasma parameters
Variable Control (n  6) IUGR (n  7) P Value
Plasma norepinephrine,
pg/ml 323  303 2216  208 0.01
Plasma insulin, ng/ml 0.32 0.05 0.15  0.05 0.04
Plasma glucose, mM 1.05 0.10 0.69  0.09 0.02
Plasma lactate, mM 1.82 0.33 3.02  0.31 0.02
Blood O2, mM 3.40  0.23 2.15  0.21 0.01
Blood O2 saturation, % 48.0  5.2 31.7  4.8 0.04
Values are means  SE; n, number of animals. IUGR, intrauterine growth
restriction.
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Fig. 1. Immunostaining for fiber type in fetal semitendinosus muscles. Repre-
sentative micrographs are depicted for control and intrauterine growth restric-
tion (IUGR) semitendinosus cross sections (8 m). Sections were stained for
myosin heavy chain (MyHC) isoforms (green) and counterstained for desmin
(red). A: Type I fibers (MyHC-I); B: Types I or IIa fibers (MyHC-I/IIa); C:
Type II fibers (MyHC-II); D: Type IIx fibers (MyHC-IIx). White magnification
bar  50 m.
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RESULTS
Morphometrics. Uterine weights were not different between
ewes carrying IUGR and control fetuses (Table 2), but placen-
tas from IUGR fetuses weighed 65% less (P  0.05) than
placentas from controls. The number of placentomes was not
different between IUGR and control fetuses, but average
weight per placentome was less (P  0.05) in IUGR fetuses.
IUGR fetuses were 65% lighter than controls (P  0.05;
Table 2). Carcass weight and carcass weight/fetal weight were
also lower (P  0.05) in IUGR fetuses. When compared with
controls, IUGR fetal brain, heart, lungs, kidneys, and spleen
were smaller (P  0.05; data not shown). Liver was also
smaller (P  0.05) in females than males, but fetal sex and
fetal treatment group did not interact. When normalized to fetal
weight (Table 2), relative brain and heart weights were greater
(P  0.05) in IUGR fetuses and relative liver, lung, kidney,
and spleen weights were not different compared with controls.
Fetal blood and plasma analysis. Plasma norepinephrine
concentrations were 690% greater (P  0.05) and plasma
insulin concentrations were 53% less (P  0.05) in IUGR
fetuses than in controls (Table 3). IUGR fetuses also had lower
(P  0.05) plasma glucose concentrations and higher (P 
0.05) plasma lactate concentrations than controls. Blood oxy-
gen content and saturation were both lower (P  0.05) in
IUGR fetuses compared with controls. Partial pressure of
carbon dioxide was not different between the two groups.
Fiber type distribution and size. Proportions of Type I fibers,
Type II fibers, combined Type I/IIa fibers, and Type IIx fibers
were identified by MyHC staining (Fig. 1). The proportion of
Type I fibers and the combined proportion of Type I/IIa fibers
were less (P  0.05) in IUGR fetuses than in controls for both
semitendinosus and biceps femoris muscles (Fig. 2), but the
proportion of Type II fibers and the proportion of Type IIx
fibers were not different between IUGR and control fetuses for
either muscle. Average cross-sectional areas were lower (P 
0.05) for all fiber types in IUGR muscles compared with
controls (Fig. 3). Proportions of Type I/IIa fibers in semiten-
dinosus muscle and Type II fibers in biceps femoris muscles
were positively correlated (P  0.05) with plasma insulin
concentrations (r  0.62 and 0.65, respectively). Proportions
of Type I and Type I/IIa fibers in semitendinosus muscles (r 

0.64 and 
0.68, respectively) and biceps femoris muscles
(r  
0.45 and 
0.70, respectively) were negatively corre-
lated (P  0.05) with plasma norepinephrine concentrations.
Skeletal muscle protein. The percentage of total MyHC that
was identified by protein electrophoretic mobility as MyHC-I
was lower (P  0.05) and the percentage identified as
MyHC-II was greater (P  0.05) in IUGR than in control
semitendinosus muscles (Fig. 4A). However, no differences in
MyHC-I or MyHC-II percentages of total MyHC were ob-
served between IUGR and control biceps femoris muscles.
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Fig. 2. Muscle fiber-type proportions. The percentages of total fibers (means
SE) are presented for control and IUGR fetal semitendinosus and biceps
femoris muscle sections. Control, open bars; IUGR, black bars. A: Type I fibers
(MyHC-I positive); B: Types I or IIa fibers (MyHC-I/IIa positive); C: Type II
fibers (MyHC-II positive); D: Type IIx fibers (MyHC-IIx positive) were
determined by immunostaining. All sections were counterstained for desmin to
determine total fiber numbers. *Differences (P  0.05) between control and
IUGR groups within each muscle.
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Immunoblot analysis showed less (P  0.05) MyHC-I in
IUGR semitendinosus muscles than in controls but similar
concentrations of MyHC-II between the two groups (Fig. 4B).
Myosin heavy chain gene expression. MyHC-I mRNA con-
centrations were less (P  0.05) in IUGR semitendinosus
muscle but greater (P  0.05) in IUGR biceps femoris muscle
compared with controls (Fig. 5). IUGR fetuses contained less
(P  0.05) MyHC-IIa mRNA than controls in both semiten-
dinosus and biceps femoris muscles. MyHC-IIx mRNA con-
centrations were not different between the two groups in either
muscle.
DISCUSSION
Our findings in hindlimb muscles from near-term fetal sheep
show that placental insufficiency-induced IUGR reduces the pro-
portion of Type I fibers alone as well as the collective proportion
of Types I and IIa, but does not alter the total proportion of Type
II fibers or the proportion of the Type IIx subgroup. Size, how-
ever, was reduced in all IUGR fibers regardless of type. Skeletal
muscle is the principal tissue for insulin-stimulated glucose utili-
zation, and muscle mass and fiber type composition greatly affect
insulin sensitivity and glucose homeostasis (34, 38, 55). Thus
smaller fibers and less Type I and IIa fibers may begin to
explain the link between IUGR and skeletal muscle insulin
resistance in adulthood (40, 63). Our morphometric data show
that the fetal response to placental insufficiency included asym-
metric growth restriction in which fetal carcass weight was
diminished to a greater extent than fetal body weight. Dispro-
portional reduction of lean tissue, especially muscle, is a
hallmark of IUGR fetuses (12, 47, 65) that has been shown to
continue throughout the lifespan of the offspring (3, 33, 43, 82,
90), leaving them at greater risk for metabolic disorders (5, 28,
61, 68, 81). Decreased oxygen and nutrient supply to the fetus
due to placental insufficiency make nutrient-sparing adapta-
tions necessary for survival, and the high metabolic plasticity
of skeletal muscle makes it an ideal tissue for nutrient sparing,
even at the expense of growth (87, 89). Indeed, our findings
indicate that fetal adaptations to IUGR conditions alter fiber-
type ratios and restrict hypertrophy of all fibers in two postural
hindlimb muscles, which would be consistent with less capac-
ity for insulin-stimulated glucose utilization.
The proportions of Type I fibers alone and the combined
proportions of Types I and IIa fibers in semitendinosus and
biceps femoris muscles were substantially reduced by IUGR,
but proportions of total Type II fibers and of Type IIx fibers
were not affected. We attribute these changes in fiber compo-
sition to differences in the responsiveness of each fiber type to
the conditions caused by placental insufficiency. Our IUGR
fetuses suffered from a 40% reduction in blood oxygen
content that stimulated a near sevenfold increase in circulating
norepinephrine, the main catecholamine secreted by the pre-
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Fig. 3. Muscle fiber cross-sectional areas. Fiber cross-sectional areas (means
SE) are presented for control and IUGR fetal semitendinosus and biceps
femoris muscle sections. Control, open bars; IUGR, black bars. A: Type I fibers
(MyHC-I positive); B: Types I or IIa fibers (MyHC-I/IIa positive); C: Type II
fibers (MyHC-II positive); D: Type IIx fibers (MyHC-IIx positive) were
determined by immunostaining. All sections were counterstained for desmin to
determine total fiber numbers. *Differences (P  0.05) between control and
IUGR groups within each muscle.
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natal adrenal gland (2). Catecholamines have been shown to
affect fetal muscle growth and development (6), and we have
demonstrated chronic, progressively worsening hypercat-
echolaminemia over the third trimester in this model previ-
ously (22, 48, 53). In rodents and lambs, 	-adrenergic agonists
have been shown to reduce the ratio of Type I to Type II fibers
(9, 37, 57, 91), presumably due to the differences in adrenergic
receptor profiles between the two fiber types (reviewed in Ref.
75). In rat muscle, for example, 	-adrenergic receptor densities
in Type I fibers are twofold to threefold greater than in Type II
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Fig. 5. Myosin heavy chain gene expression. Control, open bars; IUGR, black
bars. A: MyHC-I; B: MyHC-IIa; C: MyHC-IIx mRNA concentrations were
measured in control and IUGR semitendinosus and biceps femoris samples,
normalized to s15 mRNA concentrations and are expressed as amount relative
to controls (means SE). *Differences (P 0.05) between control and IUGR
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Fig. 4. Myosin heavy chain protein content. Control, open bars; IUGR, black
bars. A: electrophoretic mobility was used to separate MyHC-I and MyHC-II
fractions of total protein isolated from control and IUGR semitendinosus and
biceps femoris samples. The percentage of total MyHC protein (means  SE)
for MyHC-I and MyHC-II protein content are presented. *Differences (P 
0.05) between control and IUGR groups within each muscle. B: semitendino-
sus MyHC-I and MyHC-II protein content was measured by immunoblot and
normalized to 	-tubulin content and expressed as the relative density compared
with controls (means  SE). *Differences (P  0.05) between control and
IUGR groups.
R1025IUGR REDUCES TYPE I MYOFIBER EXPRESSION
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00528.2015 • www.ajpregu.org
fibers. Not surprisingly, fiber oxidative capacity closely corre-
lates with adrenergic receptor numbers as well (58, 73, 74).
Chronic administration of 	-adrenergic agonists to rats sub-
stantially downregulated receptor content in the Type I-domi-
nant soleus muscle but did not have the same effect in the Type
II-dominant extensor digitorum longus muscle (73, 74). In the
present study, higher plasma norepinephrine concentrations
were highly correlated with reductions in the proportion of
Type I fibers and in the collective proportion of Types I and
IIa, and thus it is presumable that chronic stimulation by the
high catecholamine levels in our IUGR fetuses reduced the
presence of these highly oxidative fibers. Alternatively, high
catecholamines or other factors may have delayed the normal
perinatal increase of Type I fibers that occurs in most muscles
(19, 56). In swine, for example, Type I fibers from naturally
growth-restricted (“runt”) piglets showed signs of immature
formation at birth that was not present in normal-sized litter-
mates and that disappeared within a few weeks of birth (1).
However, maternal nutrient-restriction models of IUGR in
sheep show decreased Type I fibers in offspring at 6 mo of age,
which indicates a more permanent outcome rather than a
transient delay (20).
Reduced ratios of Type I and IIa fibers in IUGR fetuses
could have major implications on glucose homeostasis. Skel-
etal muscle accounts for 80% of the body’s insulin-stimu-
lated glucose utilization (27), and insulin sensitivity is three- to
fourfold higher in Type I fibers and twofold higher in Type IIa
fibers than in Type IIx fibers (34, 38, 55). In adults, muscle-
specific insulin sensitivity is positively correlated to the per-
centage of Type I fibers and negatively correlated to the
percentage of Type IIx fibers (49), which is likely due to the
greater content of insulin receptor, Glut4, and other insulin
signaling proteins in Type I fibers (4, 15, 45). Reduced Type
I/IIa-to-Type IIx fibers ratios are common in adults suffering
from obesity, Type 2 diabetes, and metabolic syndrome (4, 77)
and have been linked to IUGR-induced low birth weight in
humans and animals (8, 40, 92). Thus it is reasonable to
conclude that the differences in fiber-type composition ob-
served in the muscles of our IUGR fetuses are part of an
adaptive response that predisposes them to metabolic compli-
cations later in life.
Insulin stimulates hypertrophic growth of fibers during late
gestation and after birth (reviewed in Ref. 14), and we previ-
ously found that adaptive programming in IUGR fetal muscle
leads to smaller fibers but not lower fiber density near term
(86). However, our previous study did not distinguish between
individual fiber types. In our present study, we show that Type
I and Type II fibers are uniformly smaller (32–37%) in both
semitendinosus and biceps femoris muscles. It is doubtful that
catecholamines were directly responsible for reduced muscle
mass in our IUGR fetuses, as 	-adrenergic agonists are in fact
commonly used to increase lean mass in food animals (9, 10).
Rather, it is more likely that rate of muscle growth is decreased
by the chronically low insulin concentrations that resulted from
the combination of high catecholamines and low glucose con-
centrations. Indeed, Bassett and Hanson (6, 7) showed that a
week-long infusion of catecholamines restricted muscle growth
in fetal sheep, but that a simultaneous insulin infusion rescued
it. It should be noted that IGF-1 and other important muscle
growth factors were not measured in this study but were
previously shown to be reduced in IUGR fetal sheep (17, 41,
79, 83). Equivalent reduction in size of the various types of
fibers despite their natural differences in insulin and adrenergic
sensitivities supports our previous findings that IUGR muscle
mass is reduced primarily by decreased myoblast proliferation
rates (86).
Perspectives and Significance
Our findings in near-term IUGR fetal sheep reveal two key
adaptive changes in skeletal muscle that may help explain
greater propensity for insulin resistance in adulthood. First, we
found that the proportions of fibers with highly oxidative
phenotypes were reduced in two different hindlimb muscles,
but proportions of the more glycolytic fiber types were normal,
which would imply lower capacity for insulin-stimulated glu-
cose utilization by these muscles. We speculate that this
change results from the greater sensitivity of oxidative fiber
types to the physiological conditions induced by placental
insufficiency, especially elevated catecholamines. Second, we
found that IUGR fibers were uniformly decreased in size
regardless of fiber type, which explains greater loss of lean
mass and more pronounced asymmetric growth patterns. The
fiber type-independent reduction in size also appears to support
our previous findings which indicate that poor muscle growth
in IUGR fetuses is primarily due to impaired myoblast func-
tion. The difference in fiber-type composition and reduction in
muscle mass observed in our IUGR fetuses have also been
observed in IUGR-born adults with metabolic disorders and
could represent mechanistic links for the fetal origins of met-
abolic dysfunction that increase the risk for obesity and Type
2 diabetes.
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